Condition: Familial Hypercholesterolaemia · Sponsor: Fundación Hipercolesterolemia Familiar
SAFEHEART is a large, on-going registry study in molecularly defined patients with heterozygous FH treated in Spain.
This description comes directly from the study's public registry record.
Pedro Mata, MD · 0034915570071 · pmata@colesterolfamiliar.org
Leopoldo Perez de Isla, MD · 0034609084225 · leopisla@hotmail.com
Always discuss trial participation with your own doctor first.
| Fundacion Hipercolesterolemia Familiar | Madrid, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02693548